Effectiveness of Rituximab in Pediatric OMS Patients.

NCT00244361 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Opsoclonus-myoclonus Syndrome
Opsoclonus
Myoclonus
Ataxia

Interventions

DRUG: rituximab

Sponsor

National Pediatric Neuroinflammation Organization, Inc.

Collaborators

[object Object]